Latest Insider Transactions at Seelos Therapeutics, Inc. (SEEL)
This section provides a real-time view of insider transactions for Seelos Therapeutics, Inc. (SEEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SEELOS THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SEELOS THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 29
2024
|
Michael Joseph Golembiewski Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
417
+0.48%
|
$417
$1.1 P/Share
|
|
Dec 01
2023
|
Raj Mehra Director |
BUY
Open market or private purchase
|
Direct |
75,757
+29.04%
|
$75,757
$1.32 P/Share
|
|
Nov 30
2023
|
Michael Joseph Golembiewski Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
83,000
+48.98%
|
$83,000
$1.21 P/Share
|
|
Aug 31
2023
|
Michael Joseph Golembiewski Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+10.78%
|
$0
$0.62 P/Share
|
|
Feb 28
2023
|
Michael Joseph Golembiewski Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+12.08%
|
$0
$0.67 P/Share
|
|
Jun 01
2022
|
Daniel J. O'Connor Director |
BUY
Open market or private purchase
|
Direct |
16,000
+50.0%
|
$0
$0.61 P/Share
|
|
May 26
2022
|
Margaret Dalesandro Director |
BUY
Open market or private purchase
|
Direct |
35,000
+50.0%
|
$0
$0.6 P/Share
|
|
Mar 31
2022
|
Raj Mehra Director |
BUY
Open market or private purchase
|
Direct |
66,667
+1.99%
|
$0
$0.85 P/Share
|
|
Feb 28
2022
|
Michael Joseph Golembiewski Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+13.74%
|
$0
$0.9 P/Share
|
|
Aug 31
2017
|
Alexander J Denner > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,104
+0.42%
|
$6,104
$1.63 P/Share
|